{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:25:14Z","timestamp":1787131514783,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173392"],"award-info":[{"award-number":["82173392"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573342"],"award-info":[{"award-number":["82573342"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203892"],"award-info":[{"award-number":["82203892"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2024A03J0846"],"award-info":[{"award-number":["2024A03J0846"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025A1515012481"],"award-info":[{"award-number":["2025A1515012481"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023B1111030006"],"award-info":[{"award-number":["2023B1111030006"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024B1515040006"],"award-info":[{"award-number":["2024B1515040006"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ50149"],"award-info":[{"award-number":["2023JJ50149"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jconrel.2026.114690","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:03:42Z","timestamp":1770397422000},"page":"114690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A robust RNAi nanoplatform for precise activation of cGAS-STING pathway and effective immune checkpoint blockade to potentiate cancer immunotherapy"],"prefix":"10.1016","volume":"392","author":[{"given":"Lei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoshan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiusheng","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoding","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7637","key":"10.1016\/j.jconrel.2026.114690_bb0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"6382","key":"10.1016\/j.jconrel.2026.114690_bb0010","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114690_bb0015","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.cell.2015.08.038","article-title":"Littman, releasing the brakes on cancer immunotherapy","volume":"162","author":"Dan","year":"2015","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jconrel.2026.114690_bb0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41568-021-00343-3","article-title":"Overcoming hurdles in cancer immunotherapy","volume":"21","author":"York","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"21","key":"10.1016\/j.jconrel.2026.114690_bb0025","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jconrel.2026.114690_bb0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114690_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.jconrel.2026.114690_bb0040","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.cell.2024.03.037","article-title":"Principles and therapeutic applications of adaptive immunity","volume":"187","author":"Chi","year":"2024","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114690_bb0045","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41577-024-01112-7","article-title":"Regulation of cGAS-STING signalling and its diversity of cellular outcomes","volume":"25","author":"Zhang","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114690_bb0050","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.jconrel.2026.114690_bb0055","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114690_bb0060","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.tcb.2022.11.001","article-title":"Cellular functions of cGAS-STING signaling","volume":"33","author":"Chen","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"6121","key":"10.1016\/j.jconrel.2026.114690_bb0065","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"issue":"7758","key":"10.1016\/j.jconrel.2026.114690_bb0070","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41586-019-1228-x","article-title":"A conserved PLPLRT\/SD motif of STING mediates the recruitment and activation of TBK1","volume":"569","author":"Zhao","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114690_bb0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrmicro.2016.190","article-title":"Cyclic di-GMP: second messenger extraordinaire","volume":"15","author":"Jenal","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114690_bb0080","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1084\/jem.20180139","article-title":"The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer","volume":"215","author":"Li","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2026.114690_bb0085","doi-asserted-by":"crossref","unstructured":"J. Li, T. Wu, W. Wang, Y. Gong, M. Lu, M. Zhang, W. Lu, Y. Zhou, Y. Yang, Hybrid nanoparticle\u2013mediated simultaneous ROS scavenging and STING activation improve the antitumor immunity of in situ vaccines, Sci. Adv. 10(38) eadn3002.","DOI":"10.1126\/sciadv.adn3002"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114690_bb0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-025-01691-5","article-title":"The cGAS\u2013STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications","volume":"18","author":"Shen","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114690_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102445","article-title":"Metal-based nanoparticles promote the activation of cGAS-STING pathway for enhanced cancer immunotherapy","volume":"58","author":"Li","year":"2024","journal-title":"Nano Today"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114690_bb0100","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/s41590-024-01872-3","article-title":"The balance of STING signaling orchestrates immunity in cancer","volume":"25","author":"Lanng","year":"2024","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114690_bb0105","article-title":"Harnessing cGAS-STING pathway for cancer immunotherapy: from bench to clinic","volume":"5","author":"Lee","year":"2022","journal-title":"Adv. Ther."},{"issue":"15","key":"10.1016\/j.jconrel.2026.114690_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202309583","article-title":"Precisely activating cGAS-STING pathway with a novel peptide-based nanoagonist to potentiate immune checkpoint blockade cancer immunotherapy","volume":"11","author":"Xing","year":"2024","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114690_bb0115","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ijrobp.2021.12.162","article-title":"Radiation therapy promotes hepatocellular carcinoma immune cloaking via PD-L1 upregulation induced by cGAS-STING activation","volume":"112","author":"Du","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114690_bb0120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","article-title":"Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer","volume":"9","author":"Sen","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2026.114690_bb0125","doi-asserted-by":"crossref","unstructured":"J. Zhao, A. Tong, J. Liu, M. Xu, P. Mi, Tumor-targeting nanocarriers amplified immunotherapy of cold tumors by STING activation and inhibiting immune evasion, Sci. Adv. 11(26) eadr1728.","DOI":"10.1126\/sciadv.adr1728"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114690_bb0130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12943-024-02186-6","article-title":"Nanomedicines harnessing cGAS-STING pathway: sparking immune revitalization to transform \u2018cold\u2019 tumors into \u2018hot\u2019 tumors","volume":"23","author":"Ying","year":"2024","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114690_bb0135","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41565-024-01624-2","article-title":"Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways","volume":"19","author":"Wang","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114690_bb0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.mattod.2024.07.004","article-title":"Targeting activation of cGAS-STING signaling pathway by engineered biomaterials for enhancing cancer immunotherapy","volume":"78","author":"Liang","year":"2024","journal-title":"Mater. Today"},{"issue":"16","key":"10.1016\/j.jconrel.2026.114690_bb0145","doi-asserted-by":"crossref","first-page":"15905","DOI":"10.1021\/acsnano.3c03962","article-title":"Manganese-based immunostimulatory metal-organic framework activates the cGAS-STING pathway for cancer metalloimmunotherapy","volume":"17","author":"Zheng","year":"2023","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114690_bb0150","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s44222-025-00337-y","article-title":"Bioengineering strategies to optimize STING agonist therapy","volume":"3","author":"Dosta","year":"2025","journal-title":"Nat. Rev. Bioeng."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114690_bb0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc3409","article-title":"Protein arginine methyltransferases and cancer","volume":"13","author":"Yang","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114690_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2008.12.013","article-title":"Protein arginine methylation in mammals: who, what, and why","volume":"33","author":"Bedford","year":"2009","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114690_bb0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.molcel.2006.11.019","article-title":"The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing","volume":"25","author":"Cheng","year":"2007","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114690_bb0170","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1074\/jbc.M109.035865","article-title":"Enzymatic activity is required for the in vivo functions of CARM1","volume":"285","author":"Kim","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114690_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-10-197","article-title":"Differential CARM1 expression in prostate and colorectal cancers","volume":"10","author":"Kim","year":"2010","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114690_bb0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccr.2013.12.007","article-title":"CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis","volume":"25","author":"Wang","year":"2014","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114690_bb0185","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41467-018-03031-3","article-title":"CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity","volume":"9","author":"Karakashev","year":"2018","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114690_bb0190","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1158\/2159-8290.CD-20-1144","article-title":"CARM1 inhibition enables immunotherapy of resistant tumors by dual action on tumor cells and T cells","volume":"11","author":"Kumar","year":"2021","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114690_bb0195","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/procel\/pwae010","article-title":"CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A","volume":"15","author":"Feng","year":"2024","journal-title":"Protein Cell"},{"issue":"4","key":"10.1016\/j.jconrel.2026.114690_bb0200","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","article-title":"Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1","volume":"71","author":"Cha","year":"2018","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114690_bb0205","article-title":"Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy","volume":"9","author":"Luis Enrique","year":"2021","journal-title":"J. ImmunoTher. Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114690_bb0210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12943-025-02274-1","article-title":"Modulating lipid metabolism by nanoparticles (NPs)-mediated ACSL3 silencing to inhibit hepatocellular carcinoma growth and metastasis","volume":"24","author":"Huang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.jconrel.2026.114690_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202305923","article-title":"Remodeling of mitochondrial metabolism by a mitochondria-targeted RNAi nanoplatform for effective cancer therapy","volume":"20","author":"Xu","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.114690_bb0220","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.actbio.2024.12.061","article-title":"Nanoparticle-mediated efficient up-regulation of GSDMD-N to induce pyroptosis and enhance NK cell-based cancer immunotherapy","volume":"193","author":"Huang","year":"2025","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114690_bb0225","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ejps.2013.05.023","article-title":"Convenient microwave-assisted synthesis of lipophilic sulfenamide prodrugs of metformin","volume":"49","author":"Huttunen","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"14","key":"10.1016\/j.jconrel.2026.114690_bb0230","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1021\/jm900274q","article-title":"The first bioreversible prodrug of metformin with improved lipophilicity and enhanced intestinal absorption","volume":"52","author":"Huttunen","year":"2009","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.jconrel.2026.114690_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500646","article-title":"Dual-responsive immunomodulatory RNAi nanoplatform for effective immune checkpoint blockade and enhanced cancer immunotherapy","volume":"14","author":"Cao","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114690_bb0240","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41416-023-02204-2","article-title":"Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?","volume":"128","author":"Lord","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.jconrel.2026.114690_bb0245","first-page":"1039","article-title":"Anti-tumor role of metformin","volume":"19","author":"Dempsey","year":"2018","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114690_bb0250","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114690_bb0255","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10549-010-1224-1","article-title":"Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents","volume":"126","author":"Goodwin","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114690_bb0260","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2024-260592","article-title":"Metformin-associated lactic acidosis: a serious complication of a common drug","volume":"17","author":"Malani","year":"2024","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jconrel.2026.114690_bb0265","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcis.2025.01.107","article-title":"Nanoparticles (NPs)-mediated silencing of GSTP1 expression to reverse chemoresistance for effective breast cancer therapy","volume":"685","author":"Shen","year":"2025","journal-title":"J. Colloid Interface Sci."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114690_bb0270","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jamaoncol.2019.3221","article-title":"Association between immune-related adverse events during anti-PD-1 therapy and tumor mutational burden","volume":"5","author":"Bomze","year":"2019","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114690_bb0275","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.cell.2021.02.011","article-title":"Understanding and treating the inflammatory adverse events of cancer immunotherapy","volume":"184","author":"Dougan","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114690_bb0280","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s40425-019-0805-8","article-title":"Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors","volume":"7","author":"Satya","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114690_bb0285","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative stress in cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.jconrel.2026.114690_bb0290","first-page":"2851","article-title":"Metformin activates the STING\/IRF3\/IFN-\u03b2 pathway by inhibiting AKT phosphorylation in pancreatic cancer","volume":"10","author":"Ren","year":"2020","journal-title":"Am. J. Cancer Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592600091X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592600091X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:32:13Z","timestamp":1787128333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592600091X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":58,"alternative-id":["S016836592600091X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114690","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A robust RNAi nanoplatform for precise activation of cGAS-STING pathway and effective immune checkpoint blockade to potentiate cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114690"}}